Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice

Toxicol Pathol. 2011 Aug;39(5):776-86. doi: 10.1177/0192623311409596. Epub 2011 May 31.

Abstract

The C57BL/6 mouse strain (or derivation of this strain) is used as a background for many transgenic mouse models. This strain has a relatively low susceptibility to chemically induced hepatocarcinogenesis compared with other commonly used experimental mouse strains. In the present study, the authors treated C57BL/6 mice with 25, 50, and 75 mg/kg of diethylnitrosamine (DEN) for 4 or 8 weeks by intraperitoneal injection to investigate the dose-response pattern of preneoplastic and neoplastic lesion formation in the liver. DEN induced preneoplastic lesions and cytokeratin 8/18-positive foci in a dose-dependent manner. In the 75 mg/kg for 8 weeks treatment group, hepatocellular adenoma, cholangioma and hemangioma, and cytokeratin 19-positive foci were also induced, but a significant decrease in body weight was observed. The suitable DEN treatment range for this strain was concluded to be from 75 mg/kg for 4 weeks (total amount = 300 mg/kg) to 50 mg/kg for 8 weeks (total amount = 400 mg/kg). These results should prove useful for future studies investigating hepatocarcinogenesis in both the background C57BL/6 strain and other transgenic mouse models derived from it.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Carcinogenicity Tests / methods*
  • Diethylnitrosamine / administration & dosage
  • Diethylnitrosamine / toxicity*
  • Disease Models, Animal*
  • Dose-Response Relationship, Drug
  • Immunohistochemistry
  • Keratin-19 / metabolism
  • Liver / anatomy & histology
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Liver Neoplasms, Experimental / chemically induced*
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / pathology
  • Mice
  • Mice, Inbred C57BL
  • Organ Size / drug effects
  • Precancerous Conditions / chemically induced*
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology
  • Random Allocation

Substances

  • Keratin-19
  • Diethylnitrosamine